Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Gene Logic helps uncover predictors of Parkinsonís
July 2007
SHARING OPTIONS:

GAITHERSBURG, Md.óGene Logic Inc. reports that a collaborative study between its Genomics Division and the Mayo Clinic has found biomarkers that predict susceptibility to Parkinson's disease and age of disease onset. This work may also provide a model for the study of other complex diseases such as Alzheimer's.
 
"The study methodology opens doors to more in-depth genetic understanding of complex diseases, demonstrating the value of our clinical and genomics assets and capabilities," says Dr. Jarlath ffrench-Mullen, Gene Logic's scientific director, central nervous system. "This study augments our intellectual property position around a growing set of useful markers for Parkinson's disease and other complex diseases, affording excellent opportunities to develop diagnostic, prognostic or therapeutic products."

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.